GPT and anemia: The most common treatment-related adverse events of any grade were neutropenia (36.0%, n = 9), leukopenia (32.0%, n = 8), elevated aspartate aminotransferase levels (28.0%, n = 7), anemia (28.0%, n = 7), elevated alanine aminotransferase levels (24.0%, n = 6), and hypoproteinemia (24.0%, n = 6).